Skip to main content

Risks and benefits of nanotechnology: How young adults perceive possible advances in nanomedicine compared with conventional treatments

Buy Article:

$51.63 plus tax (Refund Policy)

Abstract:

Attitudes to nanotechnology are widely studied and are changing fast. An experiment comparing young peoples' attitudes to nanomedicine and conventional treatment was conducted on 434 undergraduate students. They answered a number of questions about a hypothetical arthritis sufferer who was to be treated with a drug or a newly invented nanomedical technique, and requiring either one treatment or several. They were more influenced by the difference between one-shot and repeated treatments than by any difference between drug- and nanodelivery. Furthermore the two treatments that seemed most negative to participants were a drug that had to be administered repeatedly, or a nanosystem that was needed only once. Participants preferred the thought of a drug that only had to be taken once, or else a nanosystem so gentle and progressive that it only took its full effect after several administrations. There was a consistent gender difference, with male participants taking a more positive view of the risks, benefits and achievements involved in the various treatments than the female participants.

Keywords: Nanotechnology; medicine; public understanding of science; risk; vignette study

Document Type: Research Article

DOI: http://dx.doi.org/10.1080/13698570701306856

Affiliations: 1: Institute for Science and Society, Biorisks and Society (IGBiS), University of Nottingham, Nottingham, UK 2: School of Psychology, University of Nottingham, Nottingham, UK 3: Division of Primary Care, University of Nottingham, Graduate Medical School, Derby City General Hospital, Derby, UK

Publication date: June 1, 2007

More about this publication?
routledg/chrs/2007/00000009/00000002/art00004
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more